N/A N=27

Cannabis Use in Cancer Patients

Solid Tumor, Adult

Bottom Line

View on ClinicalTrials.gov: NCT03617692 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2024

Primary outcome: Primary: Likelihood of Accruing Participants: Feasibility of Enrollment — 27; 24 Participants

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: —
Age: Adult, Older Adult · 21+ yrs
Sex: All
Sponsor: University of Colorado, Denver
Primary completion: Dec 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Likelihood of Accruing Participants: Feasibility of Enrollment	27; 24	—

Summary

The goal of this study is to determine the feasibility of a human observational study of orally administered cannabis use among cancer patients.

Eligibility Criteria

Inclusion Criteria

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

Provision to sign and date the consent form.
Stated willingness to comply with all study procedures and be available for the duration of the study.
Be a female or male aged at least 21 years.
Have a diagnosis of any solid tumor type who has or is undergoing either curative or palliative treatment
Have intent or interest to use cannabis to treat their symptoms.

Exclusion Criteria

An individual who meets any of the following criteria will be excluded from participation in this study:

Report of other non-prescription drug use, such as cocaine, heroin, methamphetamine in the past 60 days
Actively seeking or in treatment for any substance use disorder
Acute illness other than cancer that could affect cognition or compliance per the decision of the study M.D.
Premenopausal females who are pregnant or trying to become pregnant. Note that pregnancy testing will not be required.
A Telephone Interview for Cognitive Status (TICS) score indicating moderate or severe cognitive impairment at screening

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03617692). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.